Japan, Aug. 14 -- SAGE THERAPEUTICS INC has got intellectual property rights for 'C7 SUBSTITUTED OXYSTEROLS AND METHODS AS NMDA MODULATORS.' Other related details are as follows:

Application Number: JP,2024-041201

Category (FI): C07J9/00,A61P43/00,111,A61K31/575

Stage: Grant (IP right granted following substantive examination.)

Filing Date: March 15, 2024

Publication Date: May 21, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....